Cargando…
Photodynamic Therapy for Eye Cancer
Photodynamic therapy is well-established as a treatment for a number of conditions in ophthalmology, principally in the field of medical retina, but less so in ocular oncology. Cancer of the eye is rare, the commonest lesions to affect the globe being choroidal melanoma (as a primary malignancy) and...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744093/ https://www.ncbi.nlm.nih.gov/pubmed/29292745 http://dx.doi.org/10.3390/biomedicines5040069 |
_version_ | 1783288684631556096 |
---|---|
author | Rundle, Paul |
author_facet | Rundle, Paul |
author_sort | Rundle, Paul |
collection | PubMed |
description | Photodynamic therapy is well-established as a treatment for a number of conditions in ophthalmology, principally in the field of medical retina, but less so in ocular oncology. Cancer of the eye is rare, the commonest lesions to affect the globe being choroidal melanoma (as a primary malignancy) and choroidal metastases (a secondary malignancy). The mainstay of treatment of such lesions remains radiotherapy in various forms, however, photodynamic therapy does have a useful role to play in the management of such patients. In this article, I hope to review the current indications, treatment regimes, and the risks and benefits of photodynamic therapy (PDT) as a treatment for eye cancer. |
format | Online Article Text |
id | pubmed-5744093 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-57440932017-12-31 Photodynamic Therapy for Eye Cancer Rundle, Paul Biomedicines Review Photodynamic therapy is well-established as a treatment for a number of conditions in ophthalmology, principally in the field of medical retina, but less so in ocular oncology. Cancer of the eye is rare, the commonest lesions to affect the globe being choroidal melanoma (as a primary malignancy) and choroidal metastases (a secondary malignancy). The mainstay of treatment of such lesions remains radiotherapy in various forms, however, photodynamic therapy does have a useful role to play in the management of such patients. In this article, I hope to review the current indications, treatment regimes, and the risks and benefits of photodynamic therapy (PDT) as a treatment for eye cancer. MDPI 2017-12-08 /pmc/articles/PMC5744093/ /pubmed/29292745 http://dx.doi.org/10.3390/biomedicines5040069 Text en © 2017 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Rundle, Paul Photodynamic Therapy for Eye Cancer |
title | Photodynamic Therapy for Eye Cancer |
title_full | Photodynamic Therapy for Eye Cancer |
title_fullStr | Photodynamic Therapy for Eye Cancer |
title_full_unstemmed | Photodynamic Therapy for Eye Cancer |
title_short | Photodynamic Therapy for Eye Cancer |
title_sort | photodynamic therapy for eye cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744093/ https://www.ncbi.nlm.nih.gov/pubmed/29292745 http://dx.doi.org/10.3390/biomedicines5040069 |
work_keys_str_mv | AT rundlepaul photodynamictherapyforeyecancer |